![AI: The Newest Member of the Lab Team?](https://www.g2intelligence.com/wp-content/uploads/2023/10/Nov23.DTET-CDI-Cancer-AI-iStock-1100x800-1-1080x675.jpg)
AI: The Newest Member of the Lab Team?
AI is an increasingly useful tool in pathology—but its full value can only be realized in collaboration with human experts.
AI is an increasingly useful tool in pathology—but its full value can only be realized in collaboration with human experts.
Diana W. Bianchi, MD, discusses how NIPT has evolved, key challenges, as well as her team’s research on using these tests to detect cancer.
Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.
A strategic partnership with Google enables more accurate whole genome sequencing with machine learning.
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.